Esperion to Participate in Jefferies London Healthcare Conference

ANN ARBOR, Mich., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and CEO, Sheldon Koenig, will present at the Jefferies London Healthcare Conference on Wednesday, November 16th, 2022.

A live audio webcast can be accessed on the investors and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company’s website for approximately 90 days.

Esperion TherapeuticsEsperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop, and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate, and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Contact:Corporate Communications[email protected]

You May Also Be Interested In

• Carahsoft Partner Pavilion Showcases Federal Healthcare Innovations at Medicaid Enterprise Systems Conference 2026 in Portland, Ore., August 17-20
• As FCC Restricts Foreign-Produced Robots, Matic, the Only American-Assembled, Privacy-Focused Home Robot in its Category, Announces Matic Cues
• Norsk Hydro: Alunorte ramps up alumina production